News Focus
News Focus
Followers 310
Posts 37495
Boards Moderated 1
Alias Born 11/14/2013

Re: sentiment_stocks post# 33716

Tuesday, 04/21/2015 9:36:34 PM

Tuesday, April 21, 2015 9:36:34 PM

Post# of 828144
NWBO can make DCVax-L lysate from large gauge needle biopsies and/or vacuum biopsy. There was a discussion a while back regarding how small of a sample can be used these days, and I provided a link to the sample size available from these techniques. It may and probably should take more than one biopsy from different tumors within the same patient, because of tumor diversity and mutation.

Personally, I think DCVax-Direct is the best solution, but the above technique would provide sufficient sample for the combinational therapy if DCVax-L were to be used in combo with CI. However, I brought up L this time since we may find that NWBO wants to further establish DCVax-Direct's efficacy and safety independently of CIs for a longer period of time before attempting combinations with CIs. Whereas, DCVax-L has nothing to fear regarding any issues of possible safety being confounded from CIs to its decade and a half of extraordinary safety.









Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News